The hospital-acquired infection (HAI) treatment market has gained substantial attention due to the rising prevalence of infections among hospitalised patients. Estimated at USD 15.95 billion in 2023, the market is projected to grow at a CAGR of 4.5% from 2024 to 2032, reaching approximately USD 23.66 billion by the end of the forecast period. Factors […]
